Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study (Q33394981)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study |
scientific article |
Statements
1 reference
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study (English)
1 reference
Philippe Moreau
1 reference
Sebastian Grosicki
1 reference
Tadeusz Robak
1 reference
Halyna Pylypenko
1 reference
Ievgenii Karamanesht
1 reference
Maria Grishunina
1 reference
Grigoriy Rekhtman
1 reference
Zvenyslava Masliak
1 reference
Anna Shubina
1 reference
Bertrand Arnulf
1 reference
Martin Kropff
1 reference
James Cavet
1 reference
Dixie-Lee Esseltine
1 reference
Huaibao Feng
1 reference
Suzette Girgis
1 reference
Helgi van de Velde
1 reference
William Deraedt
1 reference
Jean-Luc Harousseau
1 reference
18 April 2011
1 reference
1 reference
12
1 reference
431-440
1 reference
Identifiers
1 reference
1 reference